A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

Figure 8

Risk scores and 7 necroptosis-associated lncRNAs were associated with clinical-pathological features in BRCA patients. Correlation between risk score (a–c), LINC01871 (d–f), MAPT-AS1 (g–i), and SEMA3B-AS1 (j–m) and clinical-pathological features.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)